- Home
- PFIS vs RIGL Comparison
PFIS vs RIGL Comparison
Compare PFIS & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFIS | RIGL |
|---|---|---|
| Founded | 1905 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.6M | 564.7M |
| IPO Year | 1998 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PFIS | RIGL |
|---|---|---|
| Price | $69.71 | $36.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $56.00 | $45.67 |
| AVG Volume (30 Days) | 66.7K | ★ 353.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.42% | N/A |
| EPS Growth | 493.94 | ★ 1867.68 |
| EPS | ★ 1.47 | 0.44 |
| Revenue | N/A | ★ $294,282,000.00 |
| Revenue This Year | $12.01 | N/A |
| Revenue Next Year | $5.85 | $12.75 |
| P/E Ratio | ★ $46.27 | $83.68 |
| Revenue Growth | N/A | ★ 64.15 |
| 52 Week Low | $43.77 | $19.51 |
| 52 Week High | $70.54 | $52.24 |
Technical Indicators
Market Signals| Indicator | PFIS | RIGL |
|---|---|---|
| Relative Strength Index (RSI) | 63.95 | 42.92 |
| Support Level | $56.60 | $33.39 |
| Resistance Level | $70.54 | $36.95 |
| Average True Range (ATR) | 1.60 | 1.88 |
| MACD | -0.09 | -0.91 |
| Stochastic Oscillator | 81.97 | 18.52 |
Price Performance
Historical ComparisonAbout PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, equipment finance, working capital lines of credit, and construction loans, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.